v3.22.0.1
Financial Instruments (Tables)
 12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments, Measured at Fair Value on a Recurring and Non-recurring Basis
As at December 31, 2021, the carrying amount and fair value of the Company’s financial instruments were as follows:
Level 1
$		Level 2
$		Level 3
$
Carrying AmountFair ValueCarrying AmountFair ValueCarrying AmountFair Value
Assets:
Cash equivalents:
Canadian federal bonds and agency securities50,13850,138————
Corporate bonds and commercial paper267,953268,090————
Marketable securities:
U.S. term deposits900,000901,689————
U.S. federal bonds and agency securities680,436681,629————
Canadian federal bonds and agency securities1,215,6461,218,001————
Corporate bonds and commercial paper——2,469,0192,475,051——
Derivative assets:
Foreign exchange forward contracts——1,8241,824——
Equity and other investments:——————
Equity and other investments with readily determinable fair values2,782,9012,782,901——423,387423,387
Available-for-sale debt security under fair value option————205,878205,878
Liabilities:
Derivative liabilities:
Foreign exchange forward contracts——5,9265,926——
As at December 31, 2020, the carrying amount and fair value of the Company’s financial instruments were as follows: 
Level 1   
$  		Level 2
$		Level 3
$
Carrying AmountFair ValueCarrying AmountFair ValueCarrying AmountFair Value
Assets:
Cash equivalents:
U.S federal bonds174,397174,399————
Corporate bonds and commercial paper134,056134,396————
Repurchase agreements——290,000290,001——
Marketable securities:
U.S. term deposits885,000887,102————
U.S. federal bonds1,224,0521,226,657————
Canadian federal bonds24,98824,987————
Corporate bonds and commercial paper——1,550,3301,552,907——
Derivative assets:
Foreign exchange forward contracts——16,34016,340——